Akso Health (AHG) EBIT (2017 - 2019)

Akso Health has reported EBIT for 3 years, with the latest figure at -$10.3 million in Q3 2019.

• For the quarter ending Q3 2019, EBIT rose 41.06% year-over-year to -$10.3 million; the trailing twelve-month figure through Sep 2019 stood at -$53.6 million (down 177.05% YoY), and the FY2025 full-year result was -$166.3 million, down 1825.26% from the prior year.
• EBIT for Q3 2019 stood at -$10.3 million, up from -$14.7 million in the prior quarter.
• The five-year high for EBIT was $36.1 million in Q2 2018, with the low at -$17.5 million in Q3 2018.
• Historically, EBIT has averaged $6.5 million across 3 years, with a median of $10.3 million in 2017.
• The largest YoY upside for EBIT was 249.93% in 2018 against a maximum downside of 218.92% in 2018.
• Akso Health's EBIT stood at $31.6 million in 2017, then plunged by 135.23% to -$11.1 million in 2018, then grew by 7.68% to -$10.3 million in 2019.
• The last three EBIT figures came in at -$10.3 million (Q3 2019), -$14.7 million (Q1 2019), and -$11.1 million (Q4 2018), per Business Quant data.